Hims & Hers Health ( NYSE:HIMS) is positioning itself to capitalize on Novo Nordisk’s ( NYSE:NVO) mounting struggles in the ...

Last week, sales of Wegovy at one weight loss supplier soared 2,600 per cent following the Mounjaro price hike. Abdal Alvi, ...

BRITS scrambling to get hold of fat jab Mounjaro before a huge price hike have triggered a nationwide freeze on orders.

Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the ...

A Fierce Battle for Weight-Loss Supremacy The weight-loss drug market has become a battleground, ignited by the runaway ...

Morgan Stanley analysts have estimated that Lilly’s GLP-1 pill could bring in as much as $40 billion in annual sales by 2033.

Now, one Wegovy user who's been on the medication for only a week has shared an unexpected side effect of the drug - but they ...

Elli Lily said on Tuesday that its daily weight loss pill helped patients lose weight, specifically those with obesity and ...

GLP-1 drugs may lower the risk of some obesity-related cancers, according to an observational study of people who were ...

Eli Lilly's GLP-1 pill, orforglipron, shows promising trial results for weight loss and type 2 diabetes. Global regulatory ...

GLP-1 medications have been known to come with a raft of side effects, including weight loss and drastic changes to users' ...